But local life sciences industry proves more resilient than any other high-tech sector as firms raised $2.8 billion in 2022, IVC-aMoon report finds

Roche jointly sets up investment program with Israeli life-sciences VC fund aMoon, with the aim to speed up the development of new diagnostic technologies from Israel

Investors include international banking giant Credit Suisse; funding round follows the $660 million in commitments announced last year, bringing second aMoon fund to $750 million

The 'floodgates are now open' and regulators, patients and healthcare providers are all going with the flow, according to Yair Schindel of aMoon VC fund

aMoon fund, a health-tech fund, makes a $5 million investment in venture set up by Technion's Marcelle Machluf to commercialize tumor-busting technology

MDClone seeks to make medical data more accessible by creating replicas of original data without patients' information to preserve confidentiality

Approval paves way for four-year old firm to access $1.4 billion dental materials market; CEO forecasts revenues by early next year

As personalized health tech zooms ahead in Israel, a US expert stresses the need to advance without fear